In brief, osteosarcoma cells produce soluble osteolytic factors such as interleukin-6 (IL-6), IL-11, tumor necrosis factor-α, or receptor activator of NF-κB ligand (RANKL) that activate osteoclastogenesis, leading to bone degradation. The gene discussed is IL11; the disease is osteosarcoma.